Amphastar Pharmaceuticals (AMPH) News Today → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free AMPH Stock Alerts $42.33 +0.18 (+0.43%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 2 at 5:51 AM | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest UpdateAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 3,770,000 shares, a drop of 5.5% from the April 30th total of 3,990,000 shares. Based on an average trading volume of 410,500 shares, the short-interest ratio is currently 9.2 days. Currently, 10.7% of the shares of the company are sold short.May 31 at 7:59 AM | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by TD Asset Management IncTD Asset Management Inc boosted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 449.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 793,559 shares of the company's stocMay 30 at 2:06 AM | seekingalpha.comAmphastar Pharmaceuticals: Buy When Fear Is OverblownMay 28, 2024 | stocknews.com4 Pharma Stocks to Watch for Surprising Gains in JuneMay 27, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Lifted by Capital One FinancialMay 27, 2024 | marketbeat.comCapital One Financial Analysts Boost Earnings Estimates for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) - Capital One Financial increased their Q2 2024 earnings per share estimates for Amphastar Pharmaceuticals in a research note issued on Wednesday, May 22nd. Capital One Financial analyst T. Chiang now expects that the company will post eMay 26, 2024 | marketbeat.comTrexquant Investment LP Buys Shares of 38,959 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Trexquant Investment LP bought a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 38,959 shares of the comMay 25, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Increases Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Charles Schwab Investment Management Inc. lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 379,480 shares of the company's stock afMay 25, 2024 | finance.yahoo.comAmphastar Pharmaceuticals, Inc. (AMPH)May 24, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Dimensional Fund Advisors LPDimensional Fund Advisors LP reduced its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 29.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,339,142 shares of the company's stock aMay 23, 2024 | americanbankingnews.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Earns Hold Rating from Needham & Company LLCMay 22, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals Holds Steady Amidst New Approval and Competitive MarketMay 22, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Trading Up 4.6%Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading 4.6% HigherMay 22, 2024 | marketbeat.comAmphastar Pharmaceuticals' (AMPH) Hold Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Amphastar Pharmaceuticals in a report on Wednesday.May 22, 2024 | finanznachrichten.deAmphastar Pharmaceuticals, Inc.: Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation AerosolMay 22, 2024 | finance.yahoo.comAmphastar Receives FDA Approval for Albuterol Sulfate Inhalation AerosolMay 20, 2024 | seekingalpha.comAmphastar Pharmaceuticals: Profitable Pharma With Strong GrowthMay 20, 2024 | marketbeat.comBNP Paribas Financial Markets Cuts Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)BNP Paribas Financial Markets lowered its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 20.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,806 shares of the company's stock after seMay 16, 2024 | investorplace.comPatent Peril: 3 Stocks at Risk From the FTC's Drug CrusadeMay 15, 2024 | seekingalpha.comReassessing Amphastar PharmaceuticalsMay 15, 2024 | finance.yahoo.comImplied Volatility Surging for Amphastar (AMPH) Stock OptionsMay 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Globus Medical (GMED) and DENTSPLY SIRONA (XRAY)May 12, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Russell Investments Group Ltd.Russell Investments Group Ltd. reduced its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 51.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 63,667 shares of the company's stock aMay 11, 2024 | marketbeat.comMesirow Institutional Investment Management Inc. Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Mesirow Institutional Investment Management Inc. raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 37.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 252,8May 10, 2024 | finance.yahoo.comAmphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...May 10, 2024 | finance.yahoo.comAmphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)May 9, 2024 | finanznachrichten.deAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care ConferenceMay 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Erasca (ERAS)May 9, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals: Hold Rating Justified Amidst Growth Prospects and Pipeline PotentialMay 9, 2024 | insidermonkey.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up to $42.21Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up to $42.21May 9, 2024 | finance.yahoo.comAmphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...May 9, 2024 | finance.yahoo.comQ1 2024 Amphastar Pharmaceuticals Inc Earnings CallMay 9, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Receives Hold Rating from Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Amphastar Pharmaceuticals in a report on Thursday.May 8, 2024 | investorplace.comAMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024May 8, 2024 | washingtonpost.comAmphastar: Q1 Earnings SnapshotMay 7, 2024 | markets.businessinsider.comWhat Wall Street expects from Amphastar Pharmaceuticals's earningsMay 7, 2024 | marketbeat.comLSV Asset Management Has $19.64 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)LSV Asset Management boosted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 49.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 317,600 shares of the company's stock aftMay 3, 2024 | insidertrades.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Floyd F. Petersen Sells 500 SharesMay 1, 2024 | marketbeat.comAmphastar Pharmaceuticals (AMPH) Scheduled to Post Quarterly Earnings on WednesdayAmphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=418090)May 1, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Large Increase in Short InterestAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 3,870,000 shares, a growth of 5.4% from the March 31st total of 3,670,000 shares. Based on an average daily volume of 430,500 shares, the short-interest ratio is currently 9.0 days. Approximately 11.0% of the company's stock are sold short.April 30, 2024 | finance.yahoo.comAmphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024April 30, 2024 | msn.comFTC Targets ‘Junk’ Patent Listings on Ozempic and Other DrugsApril 24, 2024 | marketbeat.comLouisiana State Employees Retirement System Takes $1.16 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Louisiana State Employees Retirement System bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 18,700 shareApril 22, 2024 | marketbeat.comCalamos Advisors LLC Takes Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Calamos Advisors LLC purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 19,479 shares of the company's stock, valued at approximatelyApril 19, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Forecasted to Post FY2024 Earnings of $3.48 Per ShareAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) - Stock analysts at Capital One Financial raised their FY2024 earnings per share estimates for Amphastar Pharmaceuticals in a report released on Wednesday, April 17th. Capital One Financial analyst T. Chiang now forecasts that the companApril 18, 2024 | marketbeat.comFederated Hermes Inc. Has $202.42 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Federated Hermes Inc. decreased its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 4.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,272,761 shares of the company's stock after sellingApril 18, 2024 | marketbeat.comEquities Analysts Offer Predictions for Amphastar Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:AMPH)Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) - Equities researchers at Capital One Financial issued their Q1 2024 earnings per share estimates for shares of Amphastar Pharmaceuticals in a research report issued on Wednesday, April 17th. Capital One Financial analyst T. Chiang forecApril 18, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals Poised for Growth: Strong Generic Pipeline and Strategic Marketing Drive Buy RatingApril 16, 2024 | finance.yahoo.comNaloxone Market To Reach USD 2,478.6 Million By 2032 | DataHorizzon Research Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Do This Before July 30 2024 To Claim Trump’s Gift (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. AMPH Media Mentions By Week AMPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼1.100.77▲Average Medical News Sentiment AMPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼114▲AMPH Articles Average Week Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PTGX News Today SNDX News Today PAHC News Today CALT News Today ESPR News Today ENTA News Today ELAN News Today ASND News Today LEGN News Today CERE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.